Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts
Rifampicin is a key component of multidrug regimens not only for tuberculosis, but also nontuberculous mycobacterial infections (NTM) which are on the rise worldwide. Knowledge of the toxicity profile is important. Hepatotoxicity is a well-known side effect of Rifampicin necessitating regular liver...
Saved in:
Main Authors: | Rishi Kora, Sergey V. Brodsky, Tibor Nadasdy, Dean Agra, Anjali A. Satoskar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2018/9321621 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nontuberculous mycobacterial infections following teclistamab in multiple myeloma
by: Matthew Ho, et al.
Published: (2025-02-01) -
Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection
by: Jinjing Chai, et al.
Published: (2025-12-01) -
Dual Mycobacterial Invasion: A Case Report on Coexisting Tuberculosis and Nontuberculous Mycobacterium Infection
by: P. Prem Ananth, et al.
Published: (2025-01-01) -
Fatal Hemoptysis due to Chronic Cavitary Pulmonary Aspergillosis Complicated by Nontuberculous Mycobacterial Tuberculosis
by: Ioannis Kokkonouzis, et al.
Published: (2011-01-01) -
Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease
by: William Rae, et al.
Published: (2016-01-01)